Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer
Human epidermal growth factor receptor 2 positive (HER2+) breast cancer, as a subtype with high invasiveness and poor prognosis, faces issues of intertumoral heterogeneity and signaling pathway dysregulation leading to trastuzumab resistance in clinical treatment. Therefore, innovative therapeutic s...
Saved in:
| Main Authors: | Jingchao Gao, Tong Ye, Hongkun Miao, Mingjiang Liu, Li Wen, Yi Tian, Zhiguang Fu, Li Sun, Lihong Wang, Yu Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-10-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X25002695 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis
by: Chenye Zhao, et al.
Published: (2025-07-01) -
Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis
by: Qingqing Qin, et al.
Published: (2025-08-01) -
HIF1A/BNIP3 pathway affects ferroptosis in sepsis-induced cardiomyopathy through binding to BCL-2
by: Xiaoyue Wang, et al.
Published: (2025-12-01) -
PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis
by: Yifeng Shi, et al.
Published: (2025-08-01) -
Fucosyltransferase 11 restrains ferroptosis via upregulation GPX4 expression in gastric cancer
by: Bingbing Zhang, et al.
Published: (2025-05-01)